$47m in revenue$46m in cash costs before depreciationyou do the maths - this company is doomed even with all their reserve upgrades
AXN Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025